Filing Details
- Accession Number:
- 0001209191-14-064938
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-27 18:32:12
- Reporting Period:
- 2014-10-23
- Filing Date:
- 2014-10-27
- Accepted Time:
- 2014-10-27 18:32:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1454189 | Auspex Pharmaceuticals Inc. | ASPX | Pharmaceutical Preparations (2834) | 954862842 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1405712 | Cmea Ventures Vii Lp | One Letterman Drive Building C, Suite Cm500 San Francisco CA 94129 | No | No | Yes | No | |
1405972 | Cmea Ventures Vii (Parallel) Lp | One Letterman Drive Building C, Suite Cm500 San Francisco CA 94129 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-10-23 | 5,460 | $26.74 | 3,750,789 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-23 | 140 | $26.74 | 96,225 | No | 4 | S | Indirect | By: CMEA Ventures VII (Parallel) LP |
Common Stock | Disposition | 2014-10-24 | 10,628 | $27.09 | 3,740,161 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-24 | 272 | $27.09 | 95,953 | No | 4 | S | Indirect | By: CMEA Ventures VII (Parallel) LP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Indirect | By: CMEA Ventures VII (Parallel) LP |
No | 4 | S | Direct | |
No | 4 | S | Indirect | By: CMEA Ventures VII (Parallel) LP |
Footnotes
- The shares sold on this date were sold in multiple transactions. The price is the weighted average price per share, the actual sales price per share ranged from $26.40 to $27.135
- The shares sold on this date were sold in multiple transactions. The price is the weighted average price per share, the actual sales price per share ranged from $26.53 and $27.52.